Shares of immune-oncology company MAIA Biotechnology dropped almost 15% in their trading debut on Thursday after the IPO priced at the low end of expectations. On the flip… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3555197/-Opening-Day-Immuneoncology-company-MAIA-Biotechnology-drops-in-market-debut)
previous post
next post